|
Mountain View, California / Berlin, Germany Due to the incredible success of the 2018 Undoing Aging Conference in Berlin, Germany, SENS Research Foundation (SRF) and Forever Healthy Foundation (FHF) are pleased to announce that Undoing Aging will return in 2019. This will be an annual conference series, co-sponsored by SRF and FHF to promote awareness of age-related disease and the ongoing scientific breakthroughs in rejuvenation biotechnology. Undoing Aging 2019 will once again focus on bringing together scientists from around the globe in their respective fields who are leading the charge in combating age-related disease. It is through the collaborative efforts of these scientists, investors, policy makers, and media that we will continue to expand the rejuvenation biotechnology industry and reimagine aging. Many thanks to all of the brilliant speakers and 350 participants from 36 countries world-wide who attended this year, without whom this event could not have been such a resounding success. We look forward to an even greater event in 2019!   Mountain View, CA / Berlin, Germany
SENS Research Foundation (SRF) and Forever Healthy Foundation (FH) have announced a Forever Healthy Foundation Fellowship, sending out a Request for Proposals (RFP) for interested Post-Docs in the Rejuvenation Biotechnology space. The Fellowship will be carried out at the SRF Research Center in Mountain View, California. Applications are requested that promise progress over the course of the 3-year Fellowship in any area of Rejuvenation Biotechnology – defined as the application of the principles of regenerative medicine for the prevention and reversal of age-related disease. Degenerative aging is a consequence of the progressive accumulation of damage to tissue cellular and molecular structures over time; specific diseases of aging emerge when the cumulative burden of such damage in a particular tissue exceeds the minimum required to sustain its core biological functions. “Rejuvenation biotechnology began as a concept that few researchers understood, so our extramural research was necessarily guided by our own assessment of other researchers’ suitability, rather than by researchers coming to us with proposals. This RFP is a demonstration that that is no longer so: rejuvenation biotech has now become an established biomedical research paradigm”, explains Dr. Aubrey de Grey, Chief Science Officer of SRF. This Fellowship has been made possible through the generous support of the Forever Healthy Foundation, a private nonprofit initiative whose mission is to enable people to vastly extend their healthy lifespans and be part of the first generation to cure aging. In order to accelerate the development of therapies to bring aging under full medical control, the Forever Healthy Foundation directly supports cutting-edge research aimed at the molecular and cellular repair of damage caused by the aging process. Additional information and requirements for application can be found at: www.sens.org/2018-RFP  Mountain View, CA / Berlin, Germany
Jeanne F. Loring, a Professor and the founding Director of the Center for Regenerative Medicine at The Scripps Research Institute in La Jolla, will be speaking at the Undoing Aging 2018 Conference. Her laboratory studies human pluripotent stem cells (hPSCs), the remarkable cells that can make every cell type in the body. She is developing a patient-specific cell replacement therapy for Parkinson’s disease and a stem cell-based treatment for multiple sclerosis and studying the underlying causes of autism. With the San Diego Zoo, her lab is developing a "zoo" of induced pluripotent stem cells from endangered species to aid in their conservation. Dr. Loring serves on many scientific and bioethics advisory boards and is frequently quoted in major newspapers, appears on television and in documentary features, and gives many public lectures about science and society. She is particularly concerned with the dangers of unregulated stem cell treatments in the US and other countries (“stem cell tourism”). Dr. Loring says the UA2018 conference “is a great opportunity to share strategies for healthy aging with a diverse group of scientists and thought-leaders.”  Mountain View, CA / Berlin, Germany
We are happy to announce Dr. Anthony Atala as a speaker for the 2018 Undoing Aging Conference. Dr. Atala is the Director of Wake Forest Institute for Regenerative Medicine at Wake Forest School of Medicine and the Editor-in-Chief of Stem Cells-Translational Medicine and Current Stem Cell Research and Therapy. He is a practicing surgeon and a researcher in the area of regenerative medicine; his current work focuses on growing new human cells, tissues and organs. In 2011 he was elected to the Institute of Medicine of the National Academy of Sciences and was featured in U.S. News & World Report as one of 14 Pioneers of Medical Progress in the 21st Century. Over 14 applications of technologies developed in his laboratory have been used clinically. He is the editor of 20 books, has published over 500 journal articles, and has applied for or received over 200 national and international patents. At UA2018, Dr. Atala will be speaking on the use of 3D bioprinting applications within regenerative medicine. “Because of its precision, 3D bioprinting offers the potential to standardize the production of tissue engineered products and make them available to more patients,” Dr. Atala states.  Mountain View, CA / Berlin, Germany
We are happy to announce Dr. Michael West as a speaker for the 2018 Undoing Aging Conference. Michael D. West, Ph.D. has devoted his entire career to unraveling the mystery of the biological clock: from his scientific training with a focus on the biology of cellular aging, to his founding of Geron (short for Gerontology), to helming other successful biotechnology companies with a focus on immortal “pluripotent” cellular therapies, to authoring a popular book on human aging. AgeX and its clinical programs represent the culmination of his nearly three decades of research and development into the aging process. Dr. West has served as co-CEO of AgeX parent company, BioTime, Inc. (NYSE MKT: BTX) since 2015, and before that as CEO, starting in 2007. From 1998 to 2007, Dr. West served as CEO, President, and Chief Scientific Officer of Advanced Cell Technology, which, as Ocata Therapeutics, was acquired by Astellas Pharma of Japan in early 2016. In 1990 Dr. West founded Geron Corp. (Nasdaq: GERN), which was probably the first regenerative medicine startup, with backing from venture capital firms from Kleiner Perkins Caufield Byers, Venrock and others. For the company’s scientific team he recruited Elizabeth Blackburn, Carol Greider and Jack Szostak, who collectively went on to win the 2009 Nobel Prize in Physiology or Medicine, and for its scientific and clinical advisory board he recruited Nobel Laureates Carol Greider and James Watson, as well as Leonard Hayflick and others. While at Geron Dr. West also created the research consortium with Drs. James Thomson and John Gearhart that led to the first isolation of human embryonic stem cells. Dr. West has been a member of BioTime’s Board of Directors since 2002, is a Director of Asterias Biotherapeutics (NYSE MKT: AST) and was a Director of OncoCyte Corp (NYSE MKT: OCX) from 2013 to 2016. Dr. West received a B.S. Degree from Rensselaer Polytechnic Institute in 1976, an M.S. in Biology from Andrews University in 1982, and a Ph.D. from Baylor College of Medicine in 1989 concentrating on the biology of cellular aging. He is the author of The Immortal Cell: One Scientist’s Quest to Solve the Mystery of Human Aging (DoubleDay, 2003), as well as numerous papers in peer-reviewed scientific journals. Mountain View, CA / Berlin, Germany (December 20, 2017)
The SENS Research Foundation and the Forever Healthy Foundation today announced the 2018 Undoing Aging Conference program and speakers. Undoing Aging will take place March 15 - 17, 2018 at the Umspannwerk Alexanderplatz in Berlin, Germany. Undoing Aging 2018 is focused on the cellular and molecular repair of age-related damage as the basis of therapies to bring aging under full medical control. The conference, a joint effort of SENS Research Foundation and Forever Healthy Foundation, provides a platform for the existing scientific community that already works on damage repair and, at the same time, offers interested scientists and students a first-hand understanding of the current state of this exciting new field of biomedical research.  Mountain View, CA / Berlin, Germany
We are happy to announce Dr. Jean Hébert as a speaker for the 2018 Undoing Aging Conference. Dr. Hébert began his career focusing on understanding how organisms are generated during development with the ultimate goal of using the knowledge gained for regenerative purposes. In 1988, he began his PhD studies with Dr. Gail Martin at the University of California, San Francisco examining the regulation of embryonic stem cell differentiation and early development. Starting in 1994, as a postdoc in Dr. Susan McConnell’s lab at Stanford University, he refined his studies to understanding how extracellular factors regulate the neural stem cells that generate the neocortex, the part of our brains that we use for our highest cognitive functions. This focus continued when, in 2003, he accepted a faculty position at the Albert Einstein College of Medicine. Since then, the interest of the Hébert lab has since shifted from studying neocortex development to using the current understanding of this process to establish paradigms for neocortex repair and rejuvenation. "A no-brainer? Often overlooked by many in the aging field is the possibility of using organ, tissue, and cell replacements to reverse age-related damage – even for the brain, for which a body of evidence supports the feasibility of rejuvenation through progressive cell replacement without losing one’s self-identity.", says Dr. Hébert.  Mountain View, CA / Berlin, Germany
We are happy to announce Dr. Michele Calos as a speaker for the 2018 Undoing Aging Conference. Dr. Calos obtained a B.A. in Zoology at Oxford University, and a Ph.D. in Biochemistry and Molecular Biology at Harvard University working with Walter Gilbert. She did postdoctoral research at the University of Geneva, Switzerland, in the laboratory of Jeffrey H. Miller. Michele then accepted a faculty position at Stanford University School of Medicine, where she is now Professor in the Department of Genetics. The Calos laboratory has developed a series of vectors, methods, and cell lines useful for genome engineering and gene therapy. Notably, the lab developed the phiC31 integrase system, a phage integrase that performs sequence-specific integration in mammalian genomes. The lab is focused on developing non-viral methods for gene therapy and gene editing in muscle. "“I am excited about attending this conference, because I know it will expose me to a lot of interesting speakers and ideas that I would not otherwise encounter.“ says Dr. Calos. Mountain View, CA / Berlin, Germany
The 2018 Undoing Aging Conference will include poster sessions. In addition, a small number of posters will be selected for oral presentation. Poster topics should lie within the scope of the conference: Research contributing to the eventual postponement of age-related decline in health, with an emphasis on measures that repair damage rather than slowing its creation. Poster submissions are due on January 15, 2018. To submit your poster go to https://www.undoing-aging.org/abstracts.html  Mountain View, CA / Berlin, Germany
We are happy to announce Eric Lagasse as a speaker for the 2018 Undoing Aging Conference. Eric is an Associate Professor in the Department of Pathology, University of Pittsburgh, with a secondary appointment in Pitt’s Clinical and Translational Institute. In 1985, he received his Diplôme d'Etat de Docteur en Pharmacie from University of Strasbourg, France, and in 1989 he completed his PhD in Microbiology from the University of Basel, Switzerland. From 1989 to 1997, Dr. Lagasse completed his post-doctoral work in the Department of Developmental Biology and Pathology, Stanford University. Dr. Lagasse served as the Director, Liver Stem Cell Discovery Program at StemCells Inc, Palo Alto, California, from 1997 until he joined the McGowan Institute in 2004. Recently Dr. Lagasse founded LyGenesis, an organ regeneration company enabling a patient’s own lymph nodes to be used as bioreactors for growing surrogate organs. In Dr. Lagasse’s laboratory research is focused primarily on stem cell biology and cell-based therapy for a variety of diseases including cancer. "Dr. de Grey´s scientific schedule for the 2018 Undoing Aging Conference looks very promising. I am happy to be part of this.“ says Dr. Lagasse.  Mountain View, CA / Berlin, Germany
We are happy to announce Dr. James L. Kirkland, as speaker for the 2018 Undoing Aging Conference. James is the director of the Robert and Arlene Kogod Center on Aging at Mayo Clinic and Noaber Foundation Professor of Aging Research. He published the first article about drugs that clear senescent cells – senolytic agents. We are looking forward to Dr. Kirkland’s insights about his latest research on cellular senescence, age-related adipose tissue and metabolic dysfunction, and the development of agents and strategies for targeting fundamental aging mechanisms to treat age-related chronic diseases and disabilities. Find out more about the program of Undoing Aging 2018 SENS Research Foundation and Forever Healthy Foundation announce 2018 Undoing Aging Conference9/5/2017
Mountain View, CA / Berlin, Germany
The SENS Research Foundation and the Forever Healthy Foundation today announced the 2018 Undoing Aging Conference which will take place March 15 - 17, 2018 at the Umspannwerk Alexanderplatz in Berlin, Germany. Undoing Aging 2018 is focused on the cellular and molecular repair of age-related damage as the basis of therapies to bring aging under full medical control. The conference, a joint effort of SENS Research Foundation and Forever Healthy Foundation, provides a platform for the existing scientific community that already works on damage repair and, at the same time, offers interested scientists and students a first-hand understanding of the current state of this exciting new field of biomedical research. |
